comments
This article originally appeared at Common Dreams. It is licensed under a Creative Commons Attribution-Share Alike 3.0 License. Feel free to republish and share widely.
Advocates of a people s vaccine responded critically to an announcement Thursday from AstraZeneca that the British-Swedish pharmaceutical giant saw its profits double last year, even while supplying its coronavirus vaccine at no profit which it has pledged to do for the duration of the pandemic, as defined by the company. The performance last year marked a significant step forward for AstraZeneca. Despite the significant impact from the pandemic, we delivered double-digit revenue growth to leverage improved profitability and cash generation, CEO Pascal Soriot said in a statement about the company s 2020 results. The consistent achievements in the pipeline, the accelerating performance of our business, and the progress of the Covid-19 vaccine demonstrated what we can achieve.
Imported Chinese COVID vaccine restricted to Chinese nationals
December 10, 2020 Written by URN
The imported 4,000 doses of the Chinese experimental COVID-19 vaccine will be restricted to only Chinese nationals, Uganda s Health ministry has revealed.
The ministry came out on the matter on Tuesday after a letter by the Health minister, Dr. Ruth Jane Aceng authorizing the importation of 4,000 doses of the vaccine also known as Verocell leaked to the public.
With impending questions about the safety of the vaccine that was rolled out in October for emergency use in China and is yet to receive approval from the World Health Organization (WHO) for international use, Dr. Alfred Driwale, the head of Uganda Nat